Comparison 4. Ketanserin versus hydralazine.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Maternal death	2	124	Risk Ratio (M‐H, Fixed, 95% CI)	0.32 [0.03, 2.96]
2 Eclampsia	2	64	Risk Ratio (M‐H, Fixed, 95% CI)	0.6 [0.08, 4.24]
3 Persistent high blood pressure	3	180	Risk Ratio (M‐H, Fixed, 95% CI)	4.79 [1.95, 11.73]
4 Hypotension	2	76	Risk Ratio (M‐H, Fixed, 95% CI)	0.26 [0.07, 1.03]
5 Pulmonary oedema	1	44	Risk Ratio (M‐H, Fixed, 95% CI)	0.11 [0.01, 1.95]
6 HELLP syndrome	1	44	Risk Ratio (M‐H, Fixed, 95% CI)	0.2 [0.05, 0.81]
7 Disseminated intravascular coagulation	1	44	Risk Ratio (M‐H, Fixed, 95% CI)	3.0 [0.13, 69.87]
8 Severe maternal morbidity	1	56	Risk Ratio (M‐H, Fixed, 95% CI)	0.32 [0.09, 1.12]
9 Delivery due to fetal distress	1	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.45 [0.09, 2.33]
10 Placental abruption	2	64	Risk Ratio (M‐H, Fixed, 95% CI)	0.14 [0.02, 1.10]
11 Caesarean section	3	120	Risk Ratio (M‐H, Random, 95% CI)	0.76 [0.37, 1.58]
12 Side‐effects for the women	3	120	Risk Ratio (M‐H, Fixed, 95% CI)	0.32 [0.19, 0.53]
13 Perinatal death	2	116	Risk Ratio (M‐H, Fixed, 95% CI)	0.27 [0.05, 1.64]